Description

Diammonium Glycyrrhizinate is the ammonium salt of glycyrrhizic acid, extracted from licorice root. It exhibits strong hepatoprotective, anti-inflammatory, and membrane-stabilizing properties. Studies have shown it effectively reduces ALT/AST levels and improves liver functions in acute and chronic hepatitis patients . Tongda’s formulation is an enteric-coated capsule designed for preclinical research involving liver injury, viral hepatitis models, enzyme modulation, antioxidation, and fibrotic prevention.

Product Specifications

Mechanism of Action

Diammonium Glycyrrhizinate stabilizes hepatocyte membranes, reduces inflammation, and modulates immunity. It has been shown to significantly lower ALT/AST in viral hepatitis and reduce liver cell damage through anti-inflammatory pathways

Research Applications

• Modeling acute and chronic viral hepatitis

• Studies on ALT/AST modulation and liver enzyme regulation

• Anti-inflammatory and antioxidant mechanism exploration

• Liver fibrosis prevention and membrane integrity models

• Comparative preclinical evaluation with other licorice derivatives

Safety & Handling

• For research use only, not for clinical use

• Mild adverse events clinically include gastrointestinal discomfort, rash, and fluid retention

• Avoid use in low potassium, hypertension, heart failure, pregnant women

• Use PPE; store sealed and discard if capsules deteriorate

Core Keywords

diammonium glycyrrhizinate capsules, licorice-derived hepatoprotection, H20143422, antiviral hepatitis research compound, Tongda Moxing glycyrrhizinate, liver injury model reagent

Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. It is not approved for diagnostic, therapeutic, clinical, or veterinary use. Improper use may pose health or regulatory risks. Use only under appropriate institutional protocols.